Bulk tumor immune profiling using the NanoString platform also showed elevated expression of CD24 in tumors from the Nivo+CT arm, although it is conceivable that the overall greater viable tumor in this arm may account for increased expression of CD24 (ref. 26). Here, CD24 is linked to neoplasm.